Background and objectives : The delayed or inadequate treatments of cleft lip palate and alveolus patients always reveal challenging clinical outcomes. The modified surgical approaches would be needed to overcome…
Background and objectives : Tooth autotransplantation has developed into a safe and predictable procedure, which preserves the continuity of the dental arch and the alveolar process and provides an acceptable…
Background and objectives : Facial deformity is rated as least attractive of all deformities and orofacial cleft (OFC) is one such condition. Though comprehensive treatment for OFC is now available…
BONJ is an iatrogenic illness described in 2003. In those 10 years, therapeutic attitude has changed from more conservative to more invasive. The aim of this study is to demonstrate…
Background and objectives : BRONJ seems to be a rising entity in maxillofacial surgery, especially when focusing on oral anti-resorptive therapy. Literature of the past decade focused on diagnosis, prophylaxis…
In accordance to some contemporary scientific literature the incidence of BRONJ in patients receiving IV BPs i.v. ranges from 0.8% to 16%. Different treatment protocols of BRONJ are described in…
In 2003 began to be published the first cases of osteonecrosis of the jaws associated with the administration of intravenous bisphosphonates. The aim of our contribution is to present a…
Bisphosphonates reduce skeletal complications of bone diseases such as osteoporosis and bone metastases. During the last years, the number of patients with bisphosphonate-associated necrosis of the jaw (BP-ONJ) increased. Many…
Background and objectives : Bisphosphonates are used for treatment of bone metastases, multiple myeloma, osteoporosis and other bony diseases. Osteonecrosis of the jaw is a well known potential complication of…
We have proposed our original guidelines for management of patients receiving bisphosphonates (BPs) in 2008, and have managed 666 patients according to our guidelines till February 2013. Patients were classified…
